By Zeke Miller and Jonathan Lemire

President Joe Biden said Thursday that the U.S. will have enough supply of the COVID-19 vaccine by the end of the summer to inoculate 300 million Americans.

Biden made the announcement at the sprawling National Institutes of Health complex just outside Washington as he visited some of the nation's leading scientists on the frontlines of the fight against the disease. He toured the Viral Pathogenesis Laboratory that created the COVID-19 vaccine now manufactured by Moderna and being rolled out in the U.S. and other countries.

The U.S. is on pace to exceed Biden’s goal of administering 100 million vaccine doses in his first 100 days in office, with more than 26 million shots delivered in his first three weeks.

“That’s just the floor,” Biden said. "Our end goal is beating COVID-19.”

Biden announced on Thursday that the U.S. had secured contractual commitments from Moderna and Pfizer to deliver the 600 million doses of vaccine by the end of July — more than a month earlier than initially anticipated.

“We’re now on track to have enough supply for 300 million Americans by the end of July," he announced.

The pace of injections could increase further if a third coronavirus vaccine from drugmaker Johnson & Johnson receives approval from the Food and Drug Administration.

Speaking with Dr. Anthony Fauci, the nation's top infectious-disease specialist, Biden emphasized that his administration is doing everything possible to increase the vaccine supply and the country's capacity to deliver injections into arms.

“It’s been a hell of a learning process," Biden said.

Biden, wearing a mask, used his remarks to criticize President Donald Trump, saying he inherited “no plan to vaccinate most of the country.”

“It is no secret that the vaccination program was in much worse shape than my team and I anticipated,” he said.

To date, the Biden administration has deployed active-duty troops to help stand up mass vaccination sites in several states, as it looks to lay the groundwork for increasing the rate of vaccinations once more supply is available.

The Viral Pathogenesis Laboratory is led by Dr. Barney Graham, whose team made critical discoveries years ago that laid the groundwork for rapid development of that and other COVID-19 vaccines. Before the pandemic erupted, one of Graham’s research fellows, Dr. Kizzmekia Corbett, had been using those earlier findings to develop a vaccine for MERS, a cousin of COVID-19.

On the tour, Biden was shown the lab bench where researchers sequenced the virus and developed the precursor of the Moderna vaccine.

Armed with their prior research, Corbett and Graham had a head start when Chinese scientists shared the genetic map of the new coronavirus in January 2020. They already knew how to make spike proteins, which coat the surface of the new coronavirus and its MERS relative, that were stable enough to be used as a key vaccine ingredient.

Within days, the NIH had sent instructions to Moderna to brew up doses, and Corbett and her colleagues were setting up the key lab and animal tests that would eventually prove they were on the right track.

Associated Press Medical Writer Lauran Neergaard in Washington contributed to this report.

Share:
More In Science
UN Climate Report: Fossil Fuels are 'Choking Humanity'
In a nearly 3,700 page UN report, climate scientists outline the imminent dangers caused by climate change, saying fossil fuels are 'choking humanity.' The report calls some of the impacts of global warming 'irreversible,' warning of extreme consequences in the near future. Kristie L. Ebi, Professor of Global Health and Environmental and Occupational Health Sciences, University of Washington joined Cheddar's Opening Bell to discuss.
Fears of Potential for Climate Change Action Neglect Grow Amid Russia-Ukraine Tensions
World leaders are currently dealing with a handful of pressing issues, including Russia's invasion of Ukraine, inflation, and not to mention the COVID-19 pandemic; but it could be argued that the most pressing issue is one that has experienced its fair share of neglect in the past -- climate change. As tensions escalate between Russia and Ukraine, there is fear the focus on climate will once again be pushed aside. However, the White House appears to be making some effort to prevent that from happening. The White House Office of Science and Technology held a first-of-its-kind roundtable discussion with some of the nation's leading climate scientists on Thursday. Michael Mann, Director of the Earth System Science Center at Pennsylvania State University, and author of the book 'The New Climate War' joins Cheddar News' Closing Bell to discuss his experience as one of the climate scientists at the White House event.
NASA Veteran on New Telescope Program Looking at First Galaxies to Form in Universe
On December 25, 2021, NASA got into the holiday spirit by launching the James Webb Space Telescope, the largest and most powerful space science observatory in history. It is intended to succeed the Hubble Space Telescope as NASA's flagship mission in astrophysics and is able to view objects too old and distant for Hubble. Gregory Robinson, director of NASA's James Webb Space Telescope program, joins Cheddar News' Closing Bell to discuss the mission. "I think a lot of what we don't know today is what I'm expecting to find and certainly really understand what took place more than 13.5 billion years ago and see the formation of some of the first galaxies in our universe," said Robinson.
Leafly CEO on Big 2021 Cannabis Jobs Growth, Looking Ahead to NJ, NY Adult Use
Even amid the Great Resignation, the cannabis industry saw major job growth. As of January 2022, the legal industry supported more than 428,000 jobs — a 33 percent increase year-over-year, according to the sixth annual jobs report from Leafly, a website focused on cannabis use and education. Yoko Miyashita, CEO of Leafly, joined Cheddar News' Closing Bell to discuss. “You know we've got big moments coming ahead in New Jersey and New York with adult-use sales starting in New Jersey, hopefully by this fall, with New York quickly to follow," she said. "So we're hugely optimistic about the kind of job growth that those markets can drive with the right type of market setup.
Load More